JP2014524936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014524936A5 JP2014524936A5 JP2014523106A JP2014523106A JP2014524936A5 JP 2014524936 A5 JP2014524936 A5 JP 2014524936A5 JP 2014523106 A JP2014523106 A JP 2014523106A JP 2014523106 A JP2014523106 A JP 2014523106A JP 2014524936 A5 JP2014524936 A5 JP 2014524936A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- pharmaceutically acceptable
- prodrug
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CN1C(OC*)SCC1C(O)=O Chemical compound CN1C(OC*)SCC1C(O)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161512751P | 2011-07-28 | 2011-07-28 | |
| US61/512,751 | 2011-07-28 | ||
| PCT/US2012/048820 WO2013016727A1 (en) | 2011-07-28 | 2012-07-30 | Cysteine prodrugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014524936A JP2014524936A (ja) | 2014-09-25 |
| JP2014524936A5 true JP2014524936A5 (https=) | 2015-09-03 |
Family
ID=47601579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014523106A Pending JP2014524936A (ja) | 2011-07-28 | 2012-07-30 | システインプロドラッグ |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US9457014B2 (https=) |
| EP (1) | EP2736890A4 (https=) |
| JP (1) | JP2014524936A (https=) |
| CA (1) | CA2842106A1 (https=) |
| WO (1) | WO2013016727A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2736890A4 (en) * | 2011-07-28 | 2015-07-15 | Promentis Pharm Inc | Cysteine PRODRUGS |
| US20130338165A1 (en) * | 2012-06-15 | 2013-12-19 | Promentis Pharmaceuticals, Inc. | Use of Compounds Elevating Glutathione Levels for the Treatment of Parkinson's Disease |
| US20150045312A1 (en) * | 2013-08-12 | 2015-02-12 | Promentis Pharmaceuticals, Inc. | Use of Compounds Elevating Glutathione Levels for the Treatment of Autism, Autistic Spectrum Disorders and Fragile X Syndrome |
| EP3674297A1 (en) | 2013-11-08 | 2020-07-01 | Promentis Pharmaceuticals, Inc. | Substituted n-acetyl-l-cysteine derivatives and related compounds |
| KR20230107890A (ko) * | 2014-09-15 | 2023-07-18 | 사운드 파마슈티칼스 인코퍼레이티드 | 정신병적 장애를 치료하기 위한 방법 및 조성물 |
| HRP20241559T1 (hr) | 2016-05-18 | 2025-02-14 | Sound Pharmaceuticals Incorporated | Ebselen za uporabu u liječenju menierove bolesti |
| WO2018115010A1 (en) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
| ES2769286T3 (es) | 2016-12-20 | 2020-06-25 | Lts Lohmann Therapie Systeme Ag | Sistema terapéutico transdérmico que contiene asenapina |
| ES2881783T3 (es) | 2017-06-26 | 2021-11-30 | Lts Lohmann Therapie Systeme Ag | Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona |
| CA3084953A1 (en) | 2017-12-05 | 2019-06-13 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| AU2018378348B2 (en) | 2017-12-05 | 2024-09-19 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
| CN112533593A (zh) | 2018-06-20 | 2021-03-19 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| CA3101420A1 (en) | 2018-06-20 | 2019-12-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
| US20220098177A1 (en) * | 2018-12-31 | 2022-03-31 | Zymergen Inc. | Polymer compositions comprising compounds derived from biology |
| AU2020286441A1 (en) | 2019-06-04 | 2022-01-06 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| CN113024473B (zh) * | 2021-04-13 | 2022-08-23 | 陕西慧康生物科技有限责任公司 | 一种含有半胱氨酸的环二肽的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT995110B (it) * | 1973-08-01 | 1975-11-10 | Snam Progetti | Procedimento per la produzione di composti eterociclici e prodotti ottenuti |
| JPS6016989A (ja) | 1983-07-06 | 1985-01-28 | Shionogi & Co Ltd | オキソ飽和異項環カルボンアミドセフエム化合物 |
| AU647599B2 (en) * | 1991-03-27 | 1994-03-24 | Sankyo Company Limited | New thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators |
| AU682894B2 (en) | 1993-10-28 | 1997-10-23 | Institut National De La Recherche Agronomique | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man |
| WO2001012166A2 (en) * | 1999-08-17 | 2001-02-22 | University Of Saskatchewan Technologies Inc. | Improved treatment for acute physical insult to the central nervous system |
| US7829709B1 (en) * | 2007-08-10 | 2010-11-09 | Marquette University | Cysteine prodrugs to treat schizophrenia and drug addiction |
| WO2009100431A1 (en) * | 2008-02-07 | 2009-08-13 | Marquette University | Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
| EP2736890A4 (en) * | 2011-07-28 | 2015-07-15 | Promentis Pharm Inc | Cysteine PRODRUGS |
-
2012
- 2012-07-30 EP EP12817817.5A patent/EP2736890A4/en not_active Withdrawn
- 2012-07-30 WO PCT/US2012/048820 patent/WO2013016727A1/en not_active Ceased
- 2012-07-30 CA CA2842106A patent/CA2842106A1/en active Pending
- 2012-07-30 JP JP2014523106A patent/JP2014524936A/ja active Pending
- 2012-07-30 US US14/391,785 patent/US9457014B2/en active Active
-
2016
- 2016-06-06 US US15/174,410 patent/US20160287563A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014524936A5 (https=) | ||
| JP6804790B1 (ja) | Ｎ４−ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途 | |
| JP2015505296A5 (https=) | ||
| JP2017519781A5 (https=) | ||
| JP2017514830A5 (https=) | ||
| HRP20181169T4 (hr) | Predlijekovi fumarata i njihova upotreba u liječenju različitih bolesti | |
| HRP20201043T1 (hr) | Spojevi 4-amino-imidazokinolina | |
| US20210002295A1 (en) | Small molecule degraders that recruit dcaf15 | |
| JP2013518107A5 (https=) | ||
| JP2009263394A5 (https=) | ||
| JP2013510120A5 (https=) | ||
| RS61064B1 (sr) | Modulatori proteina jezgra hepatitisa b | |
| MD20140084A2 (en) | New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same | |
| JP2020502092A5 (https=) | ||
| US10059670B2 (en) | Synthesis of 2-carboxamide cycloamino urea derivatives | |
| HRP20161577T1 (hr) | Inhibitori replikacije virusa gripe | |
| JP2013514980A5 (https=) | ||
| JP2017525668A5 (https=) | ||
| HRP20180081T1 (hr) | Fuzionirani triciklični heterociklični spojevi kao inhibitori hiv integraze | |
| ME02576B (me) | Derivati tetrahidropirolotiazina kao inhibitori bace | |
| JP2002030084A5 (https=) | ||
| JP2019526546A5 (https=) | ||
| JP2012504560A5 (https=) | ||
| JP2014526554A5 (https=) | ||
| RU2013152626A (ru) | ХИНОНОВЫЕ СОЕДИНЕНИЯ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, ОПОСРЕДУЕМЫХ Ape1 |